Fundz

Cumulus Oncology Secures £4.1M ($5.6M) Investment Led By Eos Advisory

PRIVATEFeb 22, 2022

Amount Raised

£4.1 Million

Round Type

Venture

EdinburghBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Cumulus Oncology, Europe’s first oncology biotech creation company, has secured a £4.1 million ($5.6 million) investment led by St Andrews-based investment firm Eos Advisory. Scottish Enterprise invested alongside Eos as Cumulus plans further scale, while an additional £1.5 million ($2 million) will follow in the coming months.

Quick answer

Cumulus Oncology raised £4.1 Million in a funding round, dated February 22, 2022. Cumulus Oncology is based in Edinburgh, Scotland, United Kingdom.

How much did Cumulus Oncology raise?
Cumulus Oncology raised £4.1 Million in a funding round on February 22, 2022.
What does Cumulus Oncology do?
Cumulus Oncology Ltd. is a biopharmaceutical company focused on sourcing novel drug targets emerging from academia and developing them for clinical use.
Where is Cumulus Oncology based and how big is it?
Cumulus Oncology is based in Edinburgh, Scotland, United Kingdom. Fundz records about 28 employees.
Who are the decision-makers at Cumulus Oncology?
Fundz holds 1 contact at Cumulus Oncology. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Cumulus Oncology that raised within 45 days of this round, from Fundz verified event records.

  • Edesa Biotech raised an undisclosed amount on April 5, 2022.
  • Theriva Biologics raised $1.5M (Seed) on March 21, 2022.
  • Azora Therapeutics, Inc. (DE) raised $10M on February 17, 2022.
  • Azora Therapeutics, Inc. (DE) raised $10M (Funding Round) on February 16, 2022.
  • Structure Therapeutics raised $7M on January 10, 2022.
  • KayoThera, Inc. raised $10M (Series A) on March 24, 2022.

Who to call at Cumulus Oncology, and when

A new round usually means Cumulus Oncology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cumulus Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cumulus Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cumulus Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cumulus Oncology

Location

Edinburgh, Scotland, United Kingdom

About

Cumulus Oncology Ltd. is a biopharmaceutical company focused on sourcing novel drug targets emerging from academia and developing them for clinical use. The company specializes in creating startups from its discoveries. Cumulus is currently raising funds to support its growth and development initiatives. Their work is centered around cancer treatment advancements.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cumulus Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Cumulus Oncology's next move

See what Strategic adds

Cumulus Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.